Skip to Content

Join the 'Breast Cancer' group to help and get support from people like you.

Breast Cancer News

Related terms: Breast Cancer, inflammatory, Cancer, Breast, Carcinoma, Ductal, Carcinoma, Lobular, Ductal Carcinoma in Situ (DCIS), Ductal Carcinoma in Situ, DCIS

FDA Warns 14 Companies on Bogus Cancer 'Cures'

Posted 2 days 13 hours ago by Drugs.com

TUESDAY, April 25, 2017 – The U.S. Food and Drug Administration on Tuesday posted warning letters to 14 companies that are selling more than 65 fake cancer treatments. The bogus products include pills, capsules, powders, creams, teas, oils and treatment and diagnostic kits. They're most commonly marketed and sold without FDA approval on websites and social media platforms, the FDA announcement of its action said. The treatments are frequently advertised as "natural" and often falsely labeled as dietary supplements, the agency added. "Consumers should not use these or similar unproven products because they may be unsafe and could prevent a person from seeking an appropriate and potentially lifesaving cancer diagnosis or treatment," said Douglas Stearn. He is director of the Office of Enforcement and Import Operations in the FDA's Office of Regulatory Affairs. "We encourage people to ... Read more

Related support groups: Cancer, Breast Cancer, Melatonin, Fish Oil, Lovaza, Colorectal Cancer, Glucosamine, 5-HTP, Valerian, Creatine, Garlic, Cranberry, St. John's Wort, Turmeric, Chondroitin, Green Tea, Tryptophan, Evening Primrose, Valerian Root, CoQ10

Could Breast Milk Tests Replace Mammograms?

Posted 4 days ago by Drugs.com

SATURDAY, April 22, 2017 – Breast-milk analysis may someday offer an alternative to mammograms for women in their childbearing years, new research suggests. Because mammography isn't well-suited to the dense breasts of younger women, scientists have begun looking for other viable breast-cancer screening tools. In a preliminary study, researchers report promising results with a new technique: evaluating breast milk for signs of cancer. "We have found alterations in protein expression in the breast milk of women with breast cancer compared to women without breast cancer," said study first author Roshanak Aslebagh. "Those proteins might be a potential biomarker of breast cancer," said Aslebagh, a doctoral candidate at Clarkson University in Potsdam, N.Y. A "biomarker" can be an indicator of a disease process, a normal biological process or responses to medication. In this case, it ... Read more

Related support groups: Breast Cancer, Breast Cancer, Prevention, Diagnosis and Investigation

Second Cancers Deadlier for Younger People: Study

Posted 8 days ago by Drugs.com

THURSDAY, April 20, 2017 – When a second cancer strikes, it tends to be far more deadly in the young, a new study reveals. The findings may help explain the poor outcomes of younger cancer patients overall, the researchers added. The researchers also found that survival odds for nearly all types of cancer are better for an initial cancer than for a second, unrelated cancer. That difference is greatest among patients younger than 40, the study authors said. "Although the increased incidence of second cancers is well known among cancer survivors, less is known about outcomes of these cancers or the influence of age," said study author Theresa Keegan. Keegan is a cancer epidemiologist at the University of California, Davis Comprehensive Cancer Center. The researchers analyzed 1992-2008 data on more than 1 million cancer patients of all ages in the United States. They then looked for ... Read more

Related support groups: Depression, Cancer, Major Depressive Disorder, Breast Cancer

More Asian-American Women Getting Breast Cancer

Posted 13 days ago by Drugs.com

FRIDAY, April 14, 2017 – Breast cancer rates among Asian-Americans are steadily rising in contrast to other racial/ethnic groups, a new study suggests. Researchers from the Cancer Prevention Institute of California reviewed data from 1988 to 2013 on breast cancer among women in California from seven Asian ethnic groups. These included Chinese, Japanese, Koreans, Filipinos, Vietnamese, South Asians (Asian Indians and Pakistanis), and Southeast Asians (Cambodians, Laotians, Hmong, Thai). During the study period, all of these groups – except Japanese women – had an overall increase in breast cancer incidence. The largest increases were among Koreans, South Asians and Southeast Asians, the study authors said. "These patterns warrant additional attention to public health prioritization to target disparities in access to care, as well as further research in identifying relevant breast ... Read more

Related support groups: Breast Cancer, Breast Cancer, Metastatic, Breast Cancer, Prevention

Misunderstood Gene Tests May Lead to Unnecessary Mastectomies

Posted 15 days ago by Drugs.com

WEDNESDAY, April 12, 2017 – Close to half of breast cancer patients who chose to have a double mastectomy after genetic testing didn't actually have the gene mutations known to raise the risk of additional cancers, a new survey found. "That was a bit surprising, because we wouldn't typically expect that surgery to be conducted for women if they don't have a risk-causing gene mutation," said lead researcher Dr. Allison Kurian. She is an associate professor of medicine, health research and policy at Stanford University. The finding suggests that many women and their doctors aren't interpreting the results of genetic testing properly, she added. There are known genetic mutations that increase future risk of cancer, the most notorious of which are BRCA 1 and 2. But genetic tests also often detect mutations of uncertain significance, Kurian explained. The genes are not normal, but the ... Read more

Related support groups: Breast Cancer, Breast Cancer, Prevention, Diagnosis and Investigation, Breast Cancer - Palliative, Body Imaging

Mammogram Guidelines Have Changed, But Are Doctors Listening?

Posted 18 days ago by Drugs.com

MONDAY, April 10, 2017 – Four of five doctors still recommend annual mammograms for women in their early 40s, despite guideline changes that have pushed back the age for yearly breast cancer screening, a new survey shows. Overall, 81 percent of physicians surveyed said they suggest annual mammograms for women aged 40 to 44, while more than two-thirds recommend regular mammograms for women aged 75 or older. "Gynecologists were, in general, more likely to recommend routine mammograms," added lead researcher Dr. Archana Radhakrishnan, an internist with Johns Hopkins University in Baltimore. These practices run counter to guidelines issued by the American Cancer Society, which recommends annual screening starting at 45 and screening every other year from age 55 onward, researchers said in background notes. The doctors also are ignoring the advice of the U.S. Preventive Services Task Force ... Read more

Related support groups: Breast Cancer, Breast Cancer, Metastatic, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Breast Cancer - Palliative, Body Imaging

Can Smog Raise Breast Cancer Risk?

Posted 7 Apr 2017 by Drugs.com

THURSDAY, April 6, 2017 – Women who live where the air is thick with pollutants may be more likely to have dense breasts, a known risk factor for breast cancer, new research suggests. "It appears that women who have dense breasts have a 20 percent greater likelihood of having been exposed to smog," said study author Dr. Lusine Yaghjyan, an assistant professor of epidemiology at the University of Florida. On the other hand, women with less-dense breasts were 12 percent less likely to have been exposed to high levels of the fine particles in air pollution that can infiltrate the lungs, she added. Although other research has revealed a similar link, Yaghjyan noted this latest study is the largest to date on the topic. As to why the pollution may be linked to more dense breast tissue, "it appears some of the chemicals that might be in those fine particles [in air pollution] might have ... Read more

Related support groups: Breast Cancer, Breast Cancer, Prevention, Respiratory Tract Disease

Gene Changes May Put Childhood Cancer Survivors at Risk

Posted 4 Apr 2017 by Drugs.com

MONDAY, April 3, 2017 – Many survivors of childhood cancer have mutations in cancer-associated genes, possibly increasing their risk for cancers later in life, researchers report. The new study included more than 3,000 people who survived childhood cancer for five years or more. More than 12 percent had changes in one of 156 genes linked to increased risk of cancer, the findings showed. By age 45, more than one-quarter of the people had developed another cancer, most commonly meningioma (brain tumor), thyroid cancer, breast cancer and non-melanoma skin cancer, according to the study. The report was scheduled for presentation Monday at an American Association for Cancer Research (AACR) meeting in Washington, D.C. Research presented at medical meetings should be considered preliminary until it is published in a peer-reviewed journal. "The remarkable advances realized over the past four ... Read more

Related support groups: Cancer, Breast Cancer, Basal Cell Carcinoma, Skin Cancer, Squamous Cell Carcinoma, Soft Tissue Sarcoma, Thyroid Tumor, Liposarcoma

Ibrance (palbociclib) Receives FDA Regular Approval and Expanded Indication for First-Line HR+, HER2- Metastatic Breast Cancer

Posted 3 Apr 2017 by Drugs.com

March 31, 2017 – Pfizer Inc. (NYSE:PFE) today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) for its first-in-class cyclin dependent kinase 4/6 (CDK 4/6) inhibitor, Ibrance (palbociclib), based on the results from the confirmatory Phase 3 trial PALOMA-2. The FDA action converts the accelerated approval of Ibrance to regular approval and broadens the range of anti-hormonal therapy that may be administered with Ibrance. Ibrance now is indicated in combination with an aromatase inhibitor, expanding on its earlier indication in combination with letrozole, as initial endocrine based therapy in postmenopausal women with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) advanced or metastatic breast cancer. Ibrance is the first CDK 4/6 inhibitor approved by the FDA. Ibrance was ... Read more

Related support groups: Breast Cancer, Breast Cancer, Metastatic, Ibrance, Palbociclib

Breast Cancer 'Immunotherapy' Helps Some With Tough-to-Treat Disease

Posted 3 Apr 2017 by Drugs.com

MONDAY, April 3, 2017 – Women with a particularly aggressive form of breast cancer who responded to an new immune-focused drug gained a significant survival benefit, a new study shows. The patients all had what's known as advanced, "triple-negative" breast cancers. "Triple-negative breast cancer is an aggressive subtype of breast cancer often affecting younger women and, unfortunately, the current treatment options for metastatic disease remain limited," explained Dr. Peter Schmid. He directs the Breast Centre at St. Bartholomew's Hospital and Barts Cancer Institute in London, England. However, oncologists also stressed that many women who took the new drug, called Tecentriq (atezolizumab), failed to respond. The results of this early, phase 1 trial were to be presented Monday at the annual meeting of the American Academy of Cancer Research (AACR), in Washington, D.C. The trial ... Read more

Related support groups: Breast Cancer, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Tecentriq, Atezolizumab

Sexual Abuse May Cause Early Puberty in Girls: Study

Posted 31 Mar 2017 by Drugs.com

FRIDAY, March 31, 2017 – It's common for parents to worry that their kids are growing up too fast. But in certain cases, early puberty in girls may be linked to sexual abuse, a small study suggests. Pennsylvania State University researchers examined data from 84 girls with a history of sexual abuse and 89 girls with no history of abuse. Those who were abused entered puberty eight to 12 months earlier than those who weren't abused, the investigators found. "Though a year's difference may seem trivial in the grand scheme of a life, this accelerated maturation has been linked to concerning consequences, including behavioral and mental health problems, and reproductive cancers," said study author Jennie Noll. She is director of the Child Maltreatment Solutions Network at Penn State. Typically, children's physical and mental development occur in tandem. "High-stress situations, such as ... Read more

Related support groups: Post Traumatic Stress Disorder, Breast Cancer, Ovarian Cancer, Precocious Puberty, Sexual Deviations or Disorders

Survival Continues to Improve for Most Cancers

Posted 31 Mar 2017 by Drugs.com

FRIDAY, March 31, 2017 – Overall cancer death rates in the United States continue to fall, but racial gaps persist, a new report says. Death rates fell between 2010 and 2014 for 11 of the 16 most common cancers in men and for 13 of the most common types in women, including lung, colon, prostate and breast cancers. However, death rates rose for cancers of the liver, pancreas and brain in men and for the liver and uterus in women. And improvements in cancer survival weren't equal for all Americans. "While this report found that five-year survival for most types of cancer improved among both blacks and whites over the past several decades, racial disparities for many common cancers have persisted, and they may have increased for prostate cancer and female breast cancer," said Dr. Lynne Penberthy. She's associate director of the U.S. National Cancer Institute's Surveillance Research ... Read more

Related support groups: Cancer, Breast Cancer, Prostate Cancer, Lung Cancer, Colorectal Cancer, Renal Cell Carcinoma, Non-Small Cell Lung Cancer, Breast Cancer, Metastatic, Brain Tumor, Melanoma, Pancreatic Cancer, Skin Cancer, Osteosarcoma, Ovarian Cancer, Endometrial Cancer, Small Cell Lung Cancer, Breast Cancer - Adjuvant, Cervical Cancer, Bladder Cancer, Melanoma - Metastatic

Preventive Mastectomy Rates Vary by State

Posted 29 Mar 2017 by Drugs.com

WEDNESDAY, March 29, 2017 – In certain areas of the United States, more women diagnosed with early stage breast cancer are choosing to have the unaffected breast removed, new research finds. The study also found that younger women are especially likely to have the second breast removed. Nearly half of women under age 45 diagnosed with early breast cancer in five states opted for the procedure, said the study's senior author, Dr. Ahmedin Jemal. He's vice president of the American Cancer Society's Surveillance and Health Services Research Program. The five states are Colorado, Iowa, Missouri, Nebraska and South Dakota. The study included records from 1.2 million women from 45 states and Washington, D.C. All patients were 20 and older. All had been diagnosed with early stage breast cancer in one breast and were treated with surgery between 2004 and 2012. Between those years, the ... Read more

Related support groups: Breast Cancer, Breast Cancer, Metastatic, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Diagnosis and Investigation, Breast Cancer - Palliative, Vascular Surgery

Smokers May Be Prone to Risks From Breast Cancer Radiation Therapy

Posted 29 Mar 2017 by Drugs.com

WEDNESDAY, March 29, 2017 – Breast cancer patients who smoke have an increased risk for serious long-term complications from radiation therapy, a new study finds. "This research highlights that breast cancer patients who smoke need to be offered help and support in order to try and quit to minimize any risks from their treatment," Dr. Julie Sharp said in a Cancer Research UK news release. She's head of health information for the research and awareness charity based in the United Kingdom. "It's important to remember that modern-day radiotherapy techniques have been refined and improved to make sure it is targeted and effective while reducing the risk of side effects," Sharp added. British researchers looked at data from nearly 41,000 breast cancer patients. The information came from 75 different studies on radiation therapy for breast cancer. The researchers found that the long-term ... Read more

Related support groups: Smoking, Breast Cancer, Smoking Cessation, Breast Cancer, Metastatic, Breast Cancer - Adjuvant, Breast Cancer - Palliative, History - Radiation Therapy

Many Women Who Get Breast Cancer Gene Test Don't Need It

Posted 28 Mar 2017 by Drugs.com

TUESDAY, March 28, 2017 – An increasing number of American women who don't have breast or ovarian cancer are being tested for BRCA and BRCA2 gene mutations associated with those diseases, a new study shows. Mutations in the BRCA1 and BRCA2 genes significantly increase a woman's risk of breast cancer. These mutations are linked to 5 percent to 10 percent of all breast cancer and about 15 percent of ovarian cancers, the U.S. National Cancer Institute says. The new study found that more than 60 percent of BRCA tests are done on women without breast or ovarian cancer. In 2004, that number was just 24 percent. This increase is likely due to increased marketing of BRCA testing. This may lead women at low risk for BRCA mutations to self-refer for testing, the researchers said. While the number of low-risk women being tested has increased, BRCA testing is being underused by at-risk women, the ... Read more

Related support groups: Breast Cancer, Breast Cancer, Metastatic, Ovarian Cancer, Breast Cancer, Prevention, Diagnosis and Investigation

Page 1 2 3 ... Next

Ask a Question

Further Information

Related Condition Support Groups

Breast Cancer, Metastatic, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Breast Cancer - Palliative, Osteolytic Bone Metastases of Breast Cancer, Breast Cancer - Male, Cancer

Related Drug Support Groups

methotrexate, tamoxifen, Arimidex, fluorouracil, Femara, anastrozole, letrozole, Xeloda, Herceptin, view more... Afinitor, Aromasin, exemestane, Taxol, Taxotere, Cytoxan, Faslodex, cyclophosphamide, capecitabine, Gemzar, paclitaxel, gemcitabine, Ibrance, doxorubicin, Adriamycin, Menest, docetaxel, vinblastine, esterified estrogens, everolimus, eribulin, Tykerb, bevacizumab, Abraxane, Kadcyla, Durabolin, Deca-Durabolin, Velban, fulvestrant, Perjeta, Fareston, Durabolin 50, thiotepa, Methotrexate LPF Sodium, Ixempra, Nolvadex, Adrucil, trastuzumab, Cytadren, pertuzumab, nandrolone, lapatinib, Trexall, Tamoxifen Hexal, Hybolin Decanoate, Halotestin, Hybolin-Improved, Anabolin LA, Halaven, Tepadina, Kisqali, Docefrez, Estratab, Andryl 200, Adriamycin PFS, Androlone-D, Cytoxan Lyophilized, Androxy, fluoxymesterone, aminoglutethimide, Onxol, Neosar, ribociclib, toremifene, ixabepilone, ado-trastuzumab emtansine, palbociclib, Soltamox, paclitaxel protein-bound, Nolvadex D, Genox, Tamoxen, Tamosin, Tamofen, Emblon, Folex PFS, Adriamycin RDF, Tamone, Thioplex